Home › Trial NCT05315167
A Phase I/II Study to Evaluate the Safety, Pharmacokinetics and Efficacy of PRJ1-3024 in Subjects with Advanced Solid Tumors
- Trial IDNCT05315167
- StatusRecruiting
- PhasePhase 1/2
- Study typeInterventional
- SponsorZhuhai Yufan Biotechnologies Co., Ltd
- Enrollment267
- Start date2022-05-30
- ConditionsAdvanced Solid Tumor · Advanced Solid Malignancies
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.